[et_pb_section fb_built=”1″ admin_label=”Header & Video” _builder_version=”4.27.4″ _module_preset=”f6f78c45-59f4-4276-80e0-32269ad226de” background_color=”#EBEBEB” custom_margin=”||||false|false” locked=”off” collapsed=”on” global_colors_info=”{%22gcid-1f1bf5fb-a99d-4acc-8d9e-ddac074c158c%22:%91%22background_color_gradient_stops%22,%22background_color_gradient_stops%22,%22background_color_gradient_stops%22%93,%22gcid-a78660e1-cfc7-4771-a566-6834d6a7f06a%22:%91%22background_color_gradient_stops%22,%22background_color_gradient_stops%22,%22background_color_gradient_stops%22%93,%22gcid-24b0db87-dafa-47d9-995f-b90181e18c52%22:%91%22background_color_gradient_stops%22,%22background_color_gradient_stops%22,%22background_color_gradient_stops%22%93}”][et_pb_row _builder_version=”4.25.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.25.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_heading title=”Antibody specificity and off-target testing” _builder_version=”4.27.4″ _module_preset=”67ae7bfb-dee9-4049-bfee-5a2faf8e791d” title_text_color=”#1A283B” custom_margin=”||10px||false|false” global_colors_info=”{}”][\/et_pb_heading][et_pb_blurb use_icon=”on” font_icon=”R||divi||400″ _builder_version=”4.27.4″ _module_preset=”d248538e-e1ae-493e-b38e-1f4c5e8a6e82″ header_font=”Urbanist|–et_global_heading_font_weight|||||||” header_text_color=”#1A283B” body_font=”Urbanist|500|||||||” body_text_color=”#1A283B” custom_padding=”|||30px|false|false” header_font_size_tablet=”” header_font_size_phone=”” header_font_size_last_edited=”on|phone” custom_css_free_form=”\/* Ensure link color matches and allow underline on hover *\/||.rm-heading a { || color: #1a283b; || text-decoration: none; ||}||.rm-heading a:hover { || text-decoration: underline !important; ||}||||||” global_colors_info=”{%22gcid-1f1b4e15-7cc6-4e13-8154-74d77a956460%22:%91%22icon_color%22%93}”]<\/p>\n
[\/et_pb_blurb][et_pb_blurb title=”De-risk expensive late-stage failures with cost effective early off-target testing during lead selection” use_icon=”on” font_icon=”R||divi||400″ _builder_version=”4.27.4″ _module_preset=”d248538e-e1ae-493e-b38e-1f4c5e8a6e82″ header_font=”Urbanist|–et_global_heading_font_weight|||||||” header_text_color=”#1A283B” background_layout=”dark” custom_padding=”|||30px|false|false” header_font_size_tablet=”” header_font_size_phone=”” header_font_size_last_edited=”on|phone” global_colors_info=”{%22gcid-1f1b4e15-7cc6-4e13-8154-74d77a956460%22:%91%22icon_color%22%93}”][\/et_pb_blurb][et_pb_blurb title=”Direct antibody binding is quantified on our receptor arrays ” use_icon=”on” font_icon=”R||divi||400″ _builder_version=”4.27.4″ _module_preset=”d248538e-e1ae-493e-b38e-1f4c5e8a6e82″ header_font=”Urbanist|–et_global_heading_font_weight|||||||” header_text_color=”#1A283B” background_layout=”dark” custom_padding=”|||30px|false|false” header_font_size_tablet=”” header_font_size_phone=”” header_font_size_last_edited=”on|phone” global_colors_info=”{%22gcid-1f1b4e15-7cc6-4e13-8154-74d77a956460%22:%91%22icon_color%22%93}”][\/et_pb_blurb][et_pb_blurb title=”Test the binding specificity of 10s to 100s of antibody candidates during your discovery campaign to inform triaging” use_icon=”on” font_icon=”R||divi||400″ _builder_version=”4.27.4″ _module_preset=”d248538e-e1ae-493e-b38e-1f4c5e8a6e82″ header_font=”Urbanist|–et_global_heading_font_weight|||||||” header_text_color=”#1A283B” background_layout=”dark” custom_padding=”|||30px|false|false” header_font_size_tablet=”” header_font_size_phone=”” header_font_size_last_edited=”on|phone” global_colors_info=”{%22gcid-1f1b4e15-7cc6-4e13-8154-74d77a956460%22:%91%22icon_color%22%93}”][\/et_pb_blurb][et_pb_blurb title=”Only small amounts (50 micrograms) of antibody required” use_icon=”on” font_icon=”R||divi||400″ _builder_version=”4.27.4″ _module_preset=”d248538e-e1ae-493e-b38e-1f4c5e8a6e82″ header_font=”Urbanist|–et_global_heading_font_weight|||||||” header_text_color=”#1A283B” background_layout=”dark” custom_padding=”|||30px|false|false” header_font_size_tablet=”” header_font_size_phone=”” header_font_size_last_edited=”on|phone” global_colors_info=”{%22gcid-1f1b4e15-7cc6-4e13-8154-74d77a956460%22:%91%22icon_color%22%93}”][\/et_pb_blurb][et_pb_image src=”https:\/\/ectocellect.com\/wp-content\/uploads\/2024\/11\/Ectocellect_rationale-1-scaled.jpg” title_text=”Ectocellect_rationale (1)” disabled_on=”on|on|on” _builder_version=”4.27.4″ _module_preset=”default” border_radii=”on|17px|17px|17px|17px” disabled=”on” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_row column_structure=”1_3,2_3″ disabled_on=”on|on|on” _builder_version=”4.27.4″ _module_preset=”default” width=”100%” max_width=”1500px” disabled=”on” global_colors_info=”{}”][et_pb_column type=”1_3″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”https:\/\/ectocellect.com\/wp-content\/uploads\/2025\/11\/case-study-1.png” title_text=”case-study-1″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][et_pb_column type=”2_3″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_heading title=”Case Study 1″ _builder_version=”4.27.4″ _module_preset=”af177d2f-91a8-4f2e-87ba-17a4fb97b9b4″ title_text_align=”left” title_font_size=”25px” custom_margin=”||10px||false|false” global_colors_info=”{}”][\/et_pb_heading][et_pb_text _builder_version=”4.27.4″ _module_preset=”707627bc-2994-4635-8ae1-9f0e8da7cbac” custom_margin=”||17px||false|false” global_colors_info=”{}”]<\/p>\n
Camerilzumab (SHR-1210) is an anti-PD1 antibody that has known off-target binding to VEGFR and ULBP2 which were identified on the Ectocellect array. Camrelizumab is formatted as an IgG4.<\/span><\/p>\n [\/et_pb_text][et_pb_button button_url=”https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6343799″ url_new_window=”on” button_text=”Read More” button_alignment=”left” _builder_version=”4.27.4″ _module_preset=”default” custom_button=”on” button_text_color=”#1a283b” button_border_width=”1px” button_border_radius=”38px” button_font=”Urbanist||||||||” button_icon=”=||divi||400″ button_on_hover=”off” global_colors_info=”{}”][\/et_pb_button][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_2,1_2″ _builder_version=”4.27.4″ _module_preset=”default” width=”100%” max_width=”1500px” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.27.4″ _module_preset=”default” custom_padding=”|||30px|false|false” global_colors_info=”{}”][et_pb_image src=”https:\/\/ectocellect.com\/wp-content\/uploads\/2025\/11\/Camrelizumab.jpg” title_text=”Camrelizumab” _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.27.4″ _module_preset=”default” custom_padding=”|30px|||false|false” global_colors_info=”{}”][et_pb_heading title=”Case Study 1″ _builder_version=”4.27.4″ _module_preset=”af177d2f-91a8-4f2e-87ba-17a4fb97b9b4″ title_text_align=”left” title_font_size=”25px” custom_margin=”||10px||false|false” global_colors_info=”{}”][\/et_pb_heading][et_pb_text _builder_version=”4.27.4″ _module_preset=”707627bc-2994-4635-8ae1-9f0e8da7cbac” custom_margin=”||17px||false|false” global_colors_info=”{}”]<\/p>\n Camerilzumab (SHR-1210) is an anti-PD1 antibody that has known off-target binding to VEGFR and ULBP2 which were identified on the Ectocellect array. Camrelizumab is formatted as an IgG4.<\/span><\/p>\n [\/et_pb_text][et_pb_button button_url=”https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6343799″ url_new_window=”on” button_text=”Read More” button_alignment=”left” _builder_version=”4.27.4″ _module_preset=”default” custom_button=”on” button_text_color=”#1a283b” button_border_width=”1px” button_border_radius=”38px” button_font=”Urbanist||||||||” button_icon=”=||divi||400″ button_on_hover=”off” global_colors_info=”{}”][\/et_pb_button][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_3,2_3″ disabled_on=”on|on|on” _builder_version=”4.27.4″ _module_preset=”default” width=”100%” max_width=”1500px” disabled=”on” global_colors_info=”{}”][et_pb_column type=”1_3″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”https:\/\/ectocellect.com\/wp-content\/uploads\/2025\/11\/Case-Study-2.png” title_text=”Case-Study-2″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][et_pb_column type=”2_3″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_heading title=”Case Study 2″ _builder_version=”4.27.4″ _module_preset=”af177d2f-91a8-4f2e-87ba-17a4fb97b9b4″ title_text_align=”left” title_font_size=”25px” custom_margin=”||10px||false|false” global_colors_info=”{}”][\/et_pb_heading][et_pb_text _builder_version=”4.27.4″ _module_preset=”707627bc-2994-4635-8ae1-9f0e8da7cbac” custom_margin=”||17px||false|false” global_colors_info=”{}”]<\/p>\n An IgG1-formatted anti-PD-L1 antibody was shown to have no detectable off-target binding on the Ectocellect array. As well as the PD-L1 target, the IgG1 antibody Fc receptors were identified. <\/span><\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_2,1_2″ _builder_version=”4.27.4″ _module_preset=”default” width=”100%” max_width=”1500px” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.27.4″ _module_preset=”default” custom_padding=”|||30px|false|false” global_colors_info=”{}”][et_pb_image src=”https:\/\/ectocellect.com\/wp-content\/uploads\/2025\/11\/AntiPDL1_arrows.jpg” title_text=”AntiPDL1_arrows” _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.27.4″ _module_preset=”default” custom_padding=”|30px|||false|false” global_colors_info=”{}”][et_pb_heading title=”Case Study 2″ _builder_version=”4.27.4″ _module_preset=”af177d2f-91a8-4f2e-87ba-17a4fb97b9b4″ title_text_align=”left” title_font_size=”25px” custom_margin=”||10px||false|false” global_colors_info=”{}”][\/et_pb_heading][et_pb_text _builder_version=”4.27.4″ _module_preset=”707627bc-2994-4635-8ae1-9f0e8da7cbac” custom_margin=”||17px||false|false” global_colors_info=”{}”]<\/p>\n An IgG1-formatted anti-PD-L1 antibody was shown to have no detectable off-target binding on the Ectocellect array. As well as the PD-L1 target, the IgG1 antibody Fc receptors were identified. <\/span><\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ admin_label=”Features” _builder_version=”4.25.1″ _module_preset=”305b1d93-998f-4d0b-9707-229bb54ee3bc” background_color=”gcid-ce695d38-7b45-4ff3-bae8-e54df8b6593b” locked=”off” collapsed=”on” global_colors_info=”{%22gcid-ce695d38-7b45-4ff3-bae8-e54df8b6593b%22:%91%22background_color%22%93}”][et_pb_row _builder_version=”4.25.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.25.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_heading title=”Essential Features for Reliable Antibody Screening” _builder_version=”4.27.4″ _module_preset=”af177d2f-91a8-4f2e-87ba-17a4fb97b9b4″ title_text_align=”center” custom_margin=”||10px||false|false” global_colors_info=”{}”][\/et_pb_heading][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_3,1_3,1_3″ _builder_version=”4.25.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_3″ _builder_version=”4.25.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”High-Quality Human Receptor Arrays” use_icon=”on” font_icon=”||fa||900″ icon_color=”#1a283b” icon_alignment=”center” _builder_version=”4.27.4″ _module_preset=”01974b2a-1040-444a-8a83-78ee5b574e09″ header_text_color=”#1A283B” body_text_color=”#1A283B” background_color=”#FFFFFF” text_orientation=”center” border_width_all=”3px” border_color_all=”#1A283B” global_colors_info=”{%22gcid-d7cd5a78-aaef-4f36-82a3-4d3706015cba%22:%91%22link_text_color%22,%22link_text_color%22,%22link_text_color%22%93,%22gcid-1f1b4e15-7cc6-4e13-8154-74d77a956460%22:%91%22link_text_color%22,%22quote_text_color%22,%22quote_border_color%22,%22link_text_color%22,%22quote_text_color%22,%22quote_border_color%22%93}”]<\/p>\n Test against validated human receptor ectodomains expressed in human cells, ensuring real-world relevance.<\/p>\n [\/et_pb_blurb][\/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.25.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”Proactive Off-Target Detection” use_icon=”on” font_icon=”||fa||900″ icon_color=”#1A283B” image_icon_background_color=”#FFFFFF” icon_alignment=”center” _builder_version=”4.27.4″ _module_preset=”01974b2a-1040-444a-8a83-78ee5b574e09″ header_text_color=”#1A283B” body_text_color=”#1A283B” background_color=”#FFFFFF” text_orientation=”center” border_width_all=”3px” border_color_all=”#1A283B” border_color_all_image=”#1A283B” locked=”off” global_colors_info=”{%22gcid-d7cd5a78-aaef-4f36-82a3-4d3706015cba%22:%91%22link_text_color%22,%22link_text_color%22,%22link_text_color%22%93,%22gcid-1f1b4e15-7cc6-4e13-8154-74d77a956460%22:%91%22link_text_color%22,%22quote_text_color%22,%22quote_border_color%22,%22link_text_color%22,%22quote_text_color%22,%22quote_border_color%22,%22link_text_color%22,%22quote_text_color%22,%22quote_border_color%22%93}” border_color_all__hover_enabled=”on|desktop” border_color_all__hover=”#1A283B”]<\/p>\n Identify potential off-target interactions early, minimising costly failures and enhancing clinical trial readiness.<\/p>\n [\/et_pb_blurb][\/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.25.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”Cost-Effective, Scalable Testing” use_icon=”on” font_icon=”||fa||900″ icon_color=”#1A283B” icon_alignment=”center” _builder_version=”4.27.4″ _module_preset=”01974b2a-1040-444a-8a83-78ee5b574e09″ header_text_color=”#1A283B” body_text_color=”#1A283B” background_color=”#FFFFFF” text_orientation=”center” border_width_all=”3px” border_color_all=”#1A283B” locked=”off” global_colors_info=”{}”]<\/p>\n Our platform provides scalable testing solutions, making it feasible to screen a high number of leads efficiently.<\/p>\n [\/et_pb_blurb][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ admin_label=”Programs” module_id=”Applications” _builder_version=”4.27.2″ _module_preset=”5a41550e-bb41-40cd-9402-2df3cc893f5b” collapsed=”on” global_colors_info=”{}”][et_pb_row _builder_version=”4.27.2″ _module_preset=”default” width=”89%” max_width=”1725px” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.25.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_heading title=”Applications” _builder_version=”4.25.1″ _module_preset=”aa0ff2c6-4749-426d-995f-6fa158faee8c” title_text_color=”gcid-1f1b4e15-7cc6-4e13-8154-74d77a956460″ custom_margin=”||0px||false|false” global_colors_info=”{%22gcid-1f1b4e15-7cc6-4e13-8154-74d77a956460%22:%91%22title_text_color%22%93}”][\/et_pb_heading][et_pb_heading title=”Boost your research using the Ectocellect receptor array for:” _builder_version=”4.27.2″ _module_preset=”eba291d1-c66f-4390-936e-45a349798898″ global_colors_info=”{}”][\/et_pb_heading][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_3,1_3,1_3″ _builder_version=”4.27.4″ _module_preset=”default” width=”89%” max_width=”1686px” global_colors_info=”{}”][et_pb_column type=”1_3″ _builder_version=”4.25.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”https:\/\/ectocellect.com\/wp-content\/uploads\/2025\/10\/Application-2-1.jpg” title_text=”Application-2″ url=”https:\/\/ectocellect.com\/?page_id=125″ _builder_version=”4.27.4″ _module_preset=”922a35c2-e5b8-45c9-b5a1-02911cedc9fe” min_height=”155.8px” custom_margin=”||||false|false” global_colors_info=”{}”][\/et_pb_image][et_pb_heading title=”Antibody target deconvolution ” _builder_version=”4.27.4″ _module_preset=”592518e2-95a0-450f-8009-699fb1693990″ custom_margin=”||0px||false|false” global_colors_info=”{}”][\/et_pb_heading][et_pb_text _builder_version=”4.27.4″ _module_preset=”707627bc-2994-4635-8ae1-9f0e8da7cbac” custom_margin=”||17px||false|false” global_colors_info=”{}”]<\/p>\n Identify the targets of functional antibodies of unknown specificity.<\/p>\n [\/et_pb_text][et_pb_button button_url=”@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjEyNSJ9fQ==@” button_text=”Learn More” disabled_on=”on|on|on” _builder_version=”4.27.4″ _dynamic_attributes=”button_url” _module_preset=”dfb0e518-2979-485c-8b06-b5f2606a4bbd” custom_padding=”14px|50px|14px|40px|true|false” disabled=”on” global_colors_info=”{}”][\/et_pb_button][\/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.25.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”https:\/\/ectocellect.com\/wp-content\/uploads\/2025\/10\/Receptor-deorphanisation-1.jpg” title_text=”Receptor-deorphanisation” url=”https:\/\/ectocellect.com\/?page_id=116″ _builder_version=”4.27.4″ _module_preset=”922a35c2-e5b8-45c9-b5a1-02911cedc9fe” min_height=”199.9px” custom_margin=”||||false|false” custom_padding=”||0px|||” global_colors_info=”{}”][\/et_pb_image][et_pb_heading title=”Receptor deorphanisation ” _builder_version=”4.27.4″ _module_preset=”592518e2-95a0-450f-8009-699fb1693990″ custom_margin=”||0px||false|false” global_colors_info=”{}”][\/et_pb_heading][et_pb_text _builder_version=”4.27.4″ _module_preset=”707627bc-2994-4635-8ae1-9f0e8da7cbac” custom_margin=”||17px||false|false” global_colors_info=”{}”]<\/p>\n Discover new receptors and ligands.<\/p>\n [\/et_pb_text][et_pb_button button_url=”@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjExNiJ9fQ==@” button_text=”Learn More” disabled_on=”on|on|on” _builder_version=”4.27.4″ _dynamic_attributes=”button_url” _module_preset=”dfb0e518-2979-485c-8b06-b5f2606a4bbd” custom_padding=”14px|50px|14px|40px|true|false” disabled=”on” global_colors_info=”{}”][\/et_pb_button][\/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.25.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”https:\/\/ectocellect.com\/wp-content\/uploads\/2025\/10\/Autoantibody-target-discovery-1.jpg” title_text=”Autoantibody-target-discovery” url=”https:\/\/ectocellect.com\/?page_id=273″ _builder_version=”4.27.4″ _module_preset=”922a35c2-e5b8-45c9-b5a1-02911cedc9fe” custom_margin=”||||false|false” global_colors_info=”{}”][\/et_pb_image][et_pb_heading title=”Autoantibody target discovery ” _builder_version=”4.27.4″ _module_preset=”592518e2-95a0-450f-8009-699fb1693990″ custom_margin=”||0px||false|false” global_colors_info=”{}”][\/et_pb_heading][et_pb_text _builder_version=”4.27.4″ _module_preset=”707627bc-2994-4635-8ae1-9f0e8da7cbac” custom_margin=”||10px||false|false” custom_padding=”||5px|||” global_colors_info=”{}”]<\/p>\n Discover the targets of patient autoantibodies.<\/p>\n [\/et_pb_text][et_pb_button button_url=”@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjI3MyJ9fQ==@” button_text=”Learn More” disabled_on=”on|on|on” _builder_version=”4.27.4″ _dynamic_attributes=”button_url” _module_preset=”dfb0e518-2979-485c-8b06-b5f2606a4bbd” disabled=”on” global_colors_info=”{}”][\/et_pb_button][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ admin_label=”Footer” module_id=”Contact” _builder_version=”4.27.2″ _module_preset=”a41791f7-5e59-44e5-ab7e-f0e840e3570f” saved_tabs=”all” locked=”off” collapsed=”on” global_colors_info=”{}”][et_pb_row _builder_version=”4.25.1″ _module_preset=”default” locked=”off” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.25.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50Ijoic2l0ZV9sb2dvIiwic2V0dGluZ3MiOnt9fQ==@” title_text=”divi-logo-mark-white” url=”@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoiaG9tZV91cmwiLCJzZXR0aW5ncyI6e319@” _builder_version=”4.25.2″ _dynamic_attributes=”src,url” _module_preset=”default” max_height=”64px” custom_margin=”||20px||false|false” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_2,1_2″ _builder_version=”4.27.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.27.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_heading title=”Get in touch for a personalised consultation” _builder_version=”4.27.2″ _module_preset=”e42f8f87-2a59-4c9a-82d2-564c739f0921″ title_text_align=”left” title_text_color=”#FFFFFF” title_font_size=”58px” custom_margin=”||10px||false|false” global_colors_info=”{}”][\/et_pb_heading][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.27.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_contact_form email=”kabir.khan@york.ac.uk, gavin.wright@york.ac.uk, cliodhna@brilliantred.co.uk” custom_message=”%%Name%%||et_pb_line_break_holder||%%Email%%||et_pb_line_break_holder||%%Message%%” _builder_version=”4.27.6″ _module_preset=”default” _unique_id=”4a21cd6d-9f2d-4af0-a381-92ddc50f5ee9″ form_field_background_color=”RGBA(255,255,255,0)” form_field_text_color=”#FFFFFF” captcha_text_color=”#FFFFFF” captcha_letter_spacing=”10px” custom_button=”on” button_text_color=”#FFFFFF” button_border_radius=”32px” hover_enabled=”0″ border_radii=”on|18px|18px|18px|18px” border_width_all=”1px” border_color_all=”#FFFFFF” global_colors_info=”{}” sticky_enabled=”0″][et_pb_contact_field field_id=”Name” field_title=”Name” _builder_version=”4.16″ global_colors_info=”{}” button_text_size__hover_enabled=”off” button_one_text_size__hover_enabled=”off” button_two_text_size__hover_enabled=”off” button_text_color__hover_enabled=”off” button_one_text_color__hover_enabled=”off” button_two_text_color__hover_enabled=”off” button_border_width__hover_enabled=”off” button_one_border_width__hover_enabled=”off” button_two_border_width__hover_enabled=”off” button_border_color__hover_enabled=”off” button_one_border_color__hover_enabled=”off” button_two_border_color__hover_enabled=”off” button_border_radius__hover_enabled=”off” button_one_border_radius__hover_enabled=”off” button_two_border_radius__hover_enabled=”off” button_letter_spacing__hover_enabled=”off” button_one_letter_spacing__hover_enabled=”off” button_two_letter_spacing__hover_enabled=”off” button_bg_color__hover_enabled=”off” button_one_bg_color__hover_enabled=”off” button_two_bg_color__hover_enabled=”off”][\/et_pb_contact_field][et_pb_contact_field field_id=”Email” field_title=”Email Address” field_type=”email” _builder_version=”4.16″ global_colors_info=”{}” button_text_size__hover_enabled=”off” button_one_text_size__hover_enabled=”off” button_two_text_size__hover_enabled=”off” button_text_color__hover_enabled=”off” button_one_text_color__hover_enabled=”off” button_two_text_color__hover_enabled=”off” button_border_width__hover_enabled=”off” button_one_border_width__hover_enabled=”off” button_two_border_width__hover_enabled=”off” button_border_color__hover_enabled=”off” button_one_border_color__hover_enabled=”off” button_two_border_color__hover_enabled=”off” button_border_radius__hover_enabled=”off” button_one_border_radius__hover_enabled=”off” button_two_border_radius__hover_enabled=”off” button_letter_spacing__hover_enabled=”off” button_one_letter_spacing__hover_enabled=”off” button_two_letter_spacing__hover_enabled=”off” button_bg_color__hover_enabled=”off” button_one_bg_color__hover_enabled=”off” button_two_bg_color__hover_enabled=”off”][\/et_pb_contact_field][et_pb_contact_field field_id=”Message” field_title=”Message” field_type=”text” fullwidth_field=”on” _builder_version=”4.16″ global_colors_info=”{}” button_text_size__hover_enabled=”off” button_one_text_size__hover_enabled=”off” button_two_text_size__hover_enabled=”off” button_text_color__hover_enabled=”off” button_one_text_color__hover_enabled=”off” button_two_text_color__hover_enabled=”off” button_border_width__hover_enabled=”off” button_one_border_width__hover_enabled=”off” button_two_border_width__hover_enabled=”off” button_border_color__hover_enabled=”off” button_one_border_color__hover_enabled=”off” button_two_border_color__hover_enabled=”off” button_border_radius__hover_enabled=”off” button_one_border_radius__hover_enabled=”off” button_two_border_radius__hover_enabled=”off” button_letter_spacing__hover_enabled=”off” button_one_letter_spacing__hover_enabled=”off” button_two_letter_spacing__hover_enabled=”off” button_bg_color__hover_enabled=”off” button_one_bg_color__hover_enabled=”off” button_two_bg_color__hover_enabled=”off”][\/et_pb_contact_field][\/et_pb_contact_form][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":" Up to a third of all lead candidate antibodies display off-target binding: Read MoreCamerilzumab (SHR-1210) is an anti-PD1 antibody that has known off-target binding to VEGFR and ULBP2 which were identified on the Ectocellect array. Camrelizumab is formatted as an IgG4.Camerilzumab (SHR-1210) is an anti-PD1 antibody that has known off-target binding to VEGFR and ULBP2 […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"class_list":["post-97","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/ectocellect.com\/index.php?rest_route=\/wp\/v2\/pages\/97","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ectocellect.com\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/ectocellect.com\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/ectocellect.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ectocellect.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=97"}],"version-history":[{"count":39,"href":"https:\/\/ectocellect.com\/index.php?rest_route=\/wp\/v2\/pages\/97\/revisions"}],"predecessor-version":[{"id":448,"href":"https:\/\/ectocellect.com\/index.php?rest_route=\/wp\/v2\/pages\/97\/revisions\/448"}],"wp:attachment":[{"href":"https:\/\/ectocellect.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=97"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}